{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:43:23Z","timestamp":1757616203579,"version":"3.44.0"},"reference-count":85,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2004,10,17]]},"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:p>Surgical abortion using vacuum aspiration or dilatation and curettage has been the method of choice for termination of pregnancy up to 63 days' gestation since the 1960s. Over the last three decades many studies have explored the use of medical methods for inducing abortion at these gestations. Earlier regimens assessed the systemic and intrauterine injection of prostaglandins. This was followed in the 1980s by the introduction of the antiprogesterone, mifepristone. Since its introduction, the uptake of medical abortion has been steadily increasing in countries where it has been available for routine use. Most current clinical protocols require the use of prostaglandins in combination with anti-progesterones or antimetabolites. The safety, efficacy and acceptability of the medical regimen are now well established at all gestations of pregnancy. Provision of medical abortion increases the choice available to women, in particular those wishing to avoid surgery.<\/jats:p>","DOI":"10.1783\/0000000052972906","type":"journal-article","created":{"date-parts":[[2005,3,5]],"date-time":"2005-03-05T01:30:57Z","timestamp":1109986257000},"page":"10-14","source":"Crossref","is-referenced-by-count":3,"title":["Medical termination of pregnancy in the early first trimester"],"prefix":"10.1136","volume":"31","author":[{"given":"Haitham","family":"Hamoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian M M","family":"Flett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2005,1,1]]},"reference":[{"article-title":"The incidence of abortion worldwide. Int Fam Plann Perspect 1999; 25(Suppl.)","author":"Henshaw, S.K.; Singh, S.; Haas, T.","key":"ref_1","unstructured":"Henshaw SK, Singh S, Haas T. The incidence of abortion worldwide. Int Fam Plann Perspect 1999; 25(Suppl.): S30\u2013S38. See also http:\/\/www.agi-usa.org\/pubs\/journals\/25s3099.html [Accessed 20 August 2004]."},{"key":"ref_2","first-page":"002855","article-title":"Medical methods for first trimester abortion","author":"Kulier, R.; Gulmezoglu, A.M.; Hofmeyr, G.J.; Cheng, L.N.; Campana, A.","year":"2004","unstructured":"Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2004(2): CD002855.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/bmj.3.5716.198","article-title":"Use of prostaglandin E2 for therapeutic abortion","volume":"3","author":"Karim, S.M.; Filshie, G.M.","year":"1970","unstructured":"Karim SM, Filshie GM. Use of prostaglandin E2 for therapeutic abortion. BMJ 1970; 3: 198\u2013200.","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(70)90402-2","article-title":"Therapeutic abortion using prostaglandin F2alpha","volume":"1","author":"Karim, S.M.; Filshie, G.M.","year":"1970","unstructured":"Karim SM, Filshie GM. Therapeutic abortion using prostaglandin F2alpha. Lancet 1970; 1: 157\u2013159.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00003081-199606000-00021","article-title":"Mifepristone and first trimester abortion","volume":"39","author":"Murray, S.; Muse, K.","year":"1996","unstructured":"Murray S, Muse K. Mifepristone and first trimester abortion. Clin Obstet Gynecol 1996; 39: 474\u2013485.","journal-title":"Clin Obstet Gynecol"},{"key":"ref_6","first-page":"221","article-title":"Medical abortion in the first trimester. Best Pract Res Clin Obstet Gynaecol","volume":"16","author":"Baird, D.T.","year":"2002","unstructured":"Baird DT. Medical abortion in the first trimester. Best Pract Res Clin Obstet Gynaecol 2002; 16: 221\u2013236."},{"issue":"3","key":"ref_7","first-page":"121","article-title":"Mode of action of medical methods of abortion","volume":"55","author":"Baird, D.T.","year":"2000","unstructured":"Baird DT. Mode of action of medical methods of abortion. J Am Med Womens Assoc 2000; 55(3 Suppl.): 121\u2013126.","journal-title":"J Am Med Womens Assoc"},{"key":"ref_8","first-page":"237","article-title":"Medical abortion in the second trimester. Best Pract Res Clin Obstet Gynaecol","volume":"16","author":"Tang, O.S.; Ho, P.C.","year":"2002","unstructured":"Tang OS, Ho PC. Medical abortion in the second trimester. Best Pract Res Clin Obstet Gynaecol 2002; 16: 237\u2013246."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.OGX.0000109168.83489.66","article-title":"Misoprostol: a quarter century of use, abuse, and creative misuse","volume":"59","author":"Chong, Y.S.; Su, L.L.; Arulkumaran, S.","year":"2004","unstructured":"Chong YS, Su LL, Arulkumaran S. Misoprostol: a quarter century of use, abuse, and creative misuse. Obstet Gynecol Surv 2004; 59: 128\u2013140.","journal-title":"Obstet Gynecol Surv"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1471-0528.1988.tb06840.x","article-title":"The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin","volume":"95","author":"Swahn, M.L.; Bygdeman, M.","year":"1988","unstructured":"Swahn ML, Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol 1988; 95: 126\u2013134.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/00016349209021052","article-title":"Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women","volume":"71","author":"Ulmann, A.; Silvestre, L.; Chemama, L.; Rezvani, Y.; Renault, M.; Aguillaume, C.J.","year":"1992","unstructured":"Ulmann A, Silvestre L, Chemama L, Rezvani Y, Renault M, Aguillaume CJ, et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet Gynecol Scand 1992; 71: 278\u2013283.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.pa.36.040196.000403","article-title":"Antiprogestins: mechanism of action and contraceptive potential","volume":"36","author":"Spitz, I.M.; Croxatto, H.B.; Robbins, A.","year":"1996","unstructured":"Spitz IM, Croxatto HB, Robbins A. Antiprogestins: mechanism of action and contraceptive potential. Annu Rev Pharmacol Toxicol 1996; 36: 47\u201381.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00003081-199606000-00017","article-title":"Mifepristone: clinical pharmacology","volume":"39","author":"Robbins, A.; Spitz, I.M.","year":"1996","unstructured":"Robbins A, Spitz IM. Mifepristone: clinical pharmacology. Clin Obstet Gynecol 1996; 39: 436\u2013450.","journal-title":"Clin Obstet Gynecol"},{"key":"ref_14","first-page":"567","article-title":"Medical approaches to termination of early pregnancy","volume":"67","author":"PF, Van Look; M, Bygdeman","year":"1989","unstructured":"Van Look PF, Bygdeman M. Medical approaches to termination of early pregnancy. Bull WHO 1989; 67: 567\u2013575.","journal-title":"Bull WHO"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/humupd\/1.1.19","article-title":"Clinical uses of antiprogestogens","volume":"1","author":"PF, Van Look; von Hertzen H","year":"1995","unstructured":"Van Look PF, von Hertzen H. Clinical uses of antiprogestogens. Hum Reprod Update 1995; 1: 19\u201334.","journal-title":"Hum Reprod Update"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1568013023358924","article-title":"The antiprogestogen mifepristone: a review","volume":"2","author":"Ashok, P.W.; Wagaarachchi, P.T.; Templeton, A.","year":"2002","unstructured":"Ashok PW, Wagaarachchi PT, Templeton A. The antiprogestogen mifepristone: a review. Curr Med Chem Immunol Endocr Metab Agents 2002; 2: 71\u201390.","journal-title":"Curr Med Chem Immunol Endocr Metab Agents"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(92)90126-E","article-title":"A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability","volume":"46","year":"1992","unstructured":"Grimes DA, Mishell DR Jr, David HP. A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability. Contraception 1992; 46: 1\u201310.","journal-title":"Contraception"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(96)00252-1","article-title":"The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study \u2013 final results","volume":"55","year":"1997","unstructured":"The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study \u2013 final results. Contraception 1997; 55: 1\u20135.","journal-title":"Contraception"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1471-0528.1990.tb02516.x","article-title":"The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy","volume":"97","year":"1990","unstructured":"The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial. Br J Obstet Gynaecol 1990; 97: 480\u2013486.","journal-title":"UK Multicentre Trial. Br J Obstet Gynaecol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0010-7824(93)90079-M","article-title":"Methotrexate and misoprostol for early abortion","volume":"48","author":"Creinin, M.D.; Darney, P.D.","year":"1993","unstructured":"Creinin MD, Darney PD. Methotrexate and misoprostol for early abortion. Contraception 1993; 48: 339\u2013348.","journal-title":"Contraception"},{"issue":"3","key":"ref_21","first-page":"127","article-title":"Medical abortion alternatives to mifepristone","volume":"55","author":"Creinin, M.D.; Pymar, H.C.","year":"2000","unstructured":"Creinin MD, Pymar HC. Medical abortion alternatives to mifepristone. J Am Med Womens Assoc 2000; 55(3 Suppl.): 127\u2013132.","journal-title":"J Am Med Womens Assoc"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/sj.bjc.6601422","article-title":"Low-risk persistent gestational trophoblastic disease treated with lowdose methotrexate: efficacy, acute and long-term effects","volume":"89","author":"Khan, F.; Everard, J.; Ahmed, S.; Coleman, R.E.; Aitken, M.; Hancock, B.W.","year":"2003","unstructured":"Khan F, Everard J, Ahmed S, Coleman RE, Aitken M, Hancock BW. Low-risk persistent gestational trophoblastic disease treated with lowdose methotrexate: efficacy, acute and long-term effects. Br J Cancer 2003; 89: 2197\u20132201.","journal-title":"Br J Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1517\/14656566.4.11.2005","article-title":"Pharmacotherapy of gestational trophoblastic disease","volume":"4","author":"Lurain, JR","year":"2003","unstructured":"Lurain JR. Pharmacotherapy of gestational trophoblastic disease. Expert Opin Pharmacother 2003; 4: 2005\u20132017.","journal-title":"Expert Opin Pharmacother"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0889-8588(05)70162-3","article-title":"Paradinas FJ, Fisher RA. Recent advances in gestational trophoblastic disease","volume":"13","author":"Newlands, E.S.","year":"1999","unstructured":"Newlands ES, Paradinas FJ, Fisher RA. Recent advances in gestational trophoblastic disease. Hematol Oncol Clin North Am 1999; 13: 225\u2013244.","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref_25","first-page":"169","article-title":"Gestational trophoblastic disease. Curr Treat Options Oncol","volume":"1","author":"Schorge, J.O.; Goldstein, D.P.; Bernstein, M.R.; Berkowitz, R.S.","year":"2000","unstructured":"Schorge JO, Goldstein DP, Bernstein MR, Berkowitz RS. Gestational trophoblastic disease. Curr Treat Options Oncol 2000; 1: 169\u2013175."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0010-7824(00)00151-7","article-title":"Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion","volume":"62","author":"Creinin, MD","year":"2000","unstructured":"Creinin MD. Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion. Contraception 2000; 62: 117\u2013124.","journal-title":"Contraception"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0010-7824(96)00114-X","article-title":"Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability","volume":"54","author":"Creinin, M.D.; Burke, A.E.","year":"1996","unstructured":"Creinin MD, Burke AE. Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability. Contraception 1996; 54: 19\u201322.","journal-title":"Contraception"},{"key":"ref_28","first-page":"321","article-title":"Methotrexate and misoprostol for early abortion: a multicenter trial","volume":"53","author":"Creinin, M.D.; Vittinghoff, E.; Keder, L.; Darney, P.D.; Tiller, G.","year":"1996","unstructured":"Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception 1996; 53: 321\u2013327.","journal-title":"I. Safety and efficacy. Contraception"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/0002-9378(95)90652-5","article-title":"A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion","volume":"173","author":"Creinin, M.D.; Vittinghoff, E.; Galbraith, S.; Klaisle, C.","year":"1995","unstructured":"Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion. Am J Obstet Gynecol 1995; 173: 1578\u20131584.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0010-7824(97)00021-8","article-title":"Abortion induced with methotrexate and misoprostol: a comparison of various protocols","volume":"55","author":"Wiebe, E.R.","year":"1997","unstructured":"Wiebe ER. Abortion induced with methotrexate and misoprostol: a comparison of various protocols. Contraception 1997; 55: 159\u2013163.","journal-title":"Contraception"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0002-9378(97)70578-7","article-title":"Methotrexate pneumonitis after systemic treatment for ectopic pregnancy","volume":"176","author":"Horrigan, T.J.; Fanning, J.; Marcotte, M.P.","year":"1997","unstructured":"Horrigan TJ, Fanning J, Marcotte MP. Methotrexate pneumonitis after systemic treatment for ectopic pregnancy. Am J Obstet Gynecol 1997; 176: 714\u2013715.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0029-7844(96)00252-9","article-title":"Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases","volume":"88","author":"JD, Jr, Isaacs; RP, McGehee; BD, Cowan","year":"1996","unstructured":"Isaacs JD Jr, McGehee RP, Cowan BD. Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases. Obstet Gynecol 1996; 88: 694\u2013696.","journal-title":"Obstet Gynecol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/humrep\/16.10.2098","article-title":"Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation","volume":"16","author":"Bartley, J.B.","year":"2001","unstructured":"Bartley JB. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. Hum Reprod 2001; 16: 2098\u20132102.","journal-title":"Hum Reprod"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/HUMREP\/10.6.1521","article-title":"Randomized trial of misoprostol and Cervagem in combination with a reduced dose of mifepristone for induction of abortion","volume":"10","author":"Baird, D.T.; Sukcharoen, N.; Thong, K.J.","year":"1995","unstructured":"Baird DT, Sukcharoen N, Thong KJ. Randomized trial of misoprostol and Cervagem in combination with a reduced dose of mifepristone for induction of abortion. Hum Reprod 1995; 10: 1521\u20131527.","journal-title":"Hum Reprod"},{"key":"ref_35","first-page":"738","article-title":"Lowering the doses of mifepristone and gemeprost for early abortion: a randomised controlled trial. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation","volume":"108","year":"2001","unstructured":"Lowering the doses of mifepristone and gemeprost for early abortion: a randomised controlled trial. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Br J Obstet Gynaecol 2001; 108: 738\u2013742.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_36","first-page":"434","article-title":"Mifepristone 100 mg in abortion regimens","volume":"98","author":"Creinin, M.D.; Pymar, H.C.; Schwartz, J.L.","year":"2001","unstructured":"Creinin MD, Pymar HC, Schwartz JL. Mifepristone 100 mg in abortion regimens. Obstet Gynecol 2001; 98: 434\u2013439.","journal-title":"Obstet Gynecol"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0010-7824(89)90104-2","article-title":"Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost)","volume":"39","author":"Rodger, M.W.; Logan, A.F.; Baird, D.T.","year":"1989","unstructured":"Rodger MW, Logan AF, Baird DT. Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost). Contraception 1989; 39: 497\u2013502.","journal-title":"Contraception"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199305273282101","article-title":"Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol","volume":"328","author":"Peyron, R.; Aubeny, E.; Targosz, V.; Silvestre, L.; Renault, M.; Elkik, F.","year":"1993","unstructured":"Peyron R, Aubeny E, Targosz V, Silvestre L, Renault M, Elkik F, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328: 1509\u20131513.","journal-title":"N Engl J Med"},{"key":"ref_39","first-page":"2","article-title":"Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol","volume":"40","author":"Aubeny, E.; Peyron, R.; Turpin, C.L.; Renault, M.; Targosz, V.; Silvestre, L.","year":"1995","unstructured":"Aubeny E, Peyron R, Turpin CL, Renault M, Targosz V, Silvestre L, et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol. Int J Fertil Menopausal Stud 1995; 40(Suppl. 2): 85\u201391.","journal-title":"Int J Fertil Menopausal Stud"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz, I.M.; Bardin, C.W.; Benton, L.; Robbins, A.","year":"1998","unstructured":"Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338: 1241\u20131247.","journal-title":"N Engl J Med"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1093\/humrep\/13.10.2962","article-title":"An effective regimen for early medical abortion: a report of 2000 consecutive cases","volume":"13","author":"Ashok, P.W.; Penney, G.C.; Flett, G.M.; Templeton, A.","year":"1998","unstructured":"Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998; 13: 2962\u20132965.","journal-title":"Hum Reprod"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1046\/j.1471-0528.2002.02156.x","article-title":"Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases","volume":"109","author":"Ashok, P.W.; Templeton, A.; Wagaarachchi, P.T.; Flett, G.M.","year":"2002","unstructured":"Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynaecol 2002; 109: 1281\u20131289.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol","volume":"332","author":"H, El Refaey; D, Rajasekar; M, Abdalla; L, Calder; A, Templeton","year":"1995","unstructured":"El Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983\u2013987.","journal-title":"N Engl J Med"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman, M.; Fong, S.K.; Benowitz, N.L.; Banskter, D.; Darney, P.D.","year":"1997","unstructured":"Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997; 90: 88\u201392.","journal-title":"Obstet Gynecol"},{"key":"ref_45","first-page":"2205","article-title":"Randomized comparison of vaginal","volume":"15","author":"Ngai, S.W.; Tang, O.S.; Ho, P.C.","year":"2000","unstructured":"Ngai SW, Tang OS, Ho PC. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Reprod 2000; 15: 2205\u20132208.","journal-title":"Hum Reprod; every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0029-7844(97)00419-5","article-title":"Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy","volume":"90","author":"Ho, P.C.; Ngai, S.W.; Liu, K.L.; Wong, G.C.; Lee, S.W.","year":"1997","unstructured":"Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol 1997; 90: 735\u2013738.","journal-title":"Obstet Gynecol"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1471-0528.1997.tb12028.x","article-title":"Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial","volume":"104","author":"Howie, F.L.; Henshaw, R.C.; Naji, S.A.; Russell, I.T.; Templeton, A.A.","year":"1997","unstructured":"Howie FL, Henshaw RC, Naji SA, Russell IT, Templeton AA. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol 1997; 104: 829\u2013833.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(01)00261-X","article-title":"Pilot study on the use of sublingual misoprostol for medical abortion","volume":"64","author":"Tang, O.S.; Ho, P.C.","year":"2001","unstructured":"Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception 2001; 64: 315\u2013317.","journal-title":"Contraception"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/humrep\/17.3.654","article-title":"Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks\u2019 gestation: efficacy and acceptability","volume":"17","author":"Tang, O.S.; Miao, B.Y.; Lee, S.W.H.; Ho, P.C.","year":"2002","unstructured":"Tang OS, Miao BY, Lee SWH, Ho PC. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks\u2019 gestation: efficacy and acceptability. Hum Reprod 2002; 17: 654\u2013658.","journal-title":"Hum Reprod"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1006701600323","article-title":"Pilot study on the use of repeated doses of misoprostol in termination of pregnancy at less than 9 weeks\u2019","volume":"15","author":"Tang, O.S.; Wong, K.S.; Tang, L.C.; Ho, P.C.","year":"1999","unstructured":"Tang OS, Wong KS, Tang LC, Ho PC. Pilot study on the use of repeated doses of misoprostol in termination of pregnancy at less than 9 weeks\u2019 of gestation. Adv Contracept 1999; 15: 211\u2013216.","journal-title":"of gestation. Adv Contracept"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/deg475","article-title":"A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks\u2019","volume":"18","author":"Tang OS, Chan CC, Ng EH, Lee SW, Ho PC","year":"2003","unstructured":"Tang OS, Chan CC, Ng EH, Lee SW, Ho PC. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks\u2019 gestation. Hum Reprod 2003; 18: 2315\u20132318.","journal-title":"gestation. Hum Reprod"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.contraception.2003.07.004","article-title":"A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days\u2019","volume":"68","author":"Hamoda, H.; Ashok, P.W.; Dow, J.; Flett, G.M.; Templeton, A.","year":"2003","unstructured":"Hamoda H, Ashok PW, Dow J, Flett GM, Templeton A. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days\u2019 gestation. Contraception 2003; 68: 335\u2013338.","journal-title":"gestation. Contraception"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang, O.S.; Schweer, H.; Seyberth, H.W.; Lee, S.W.H.; Ho, P.C.","year":"2002","unstructured":"Tang OS, Schweer H, Seyberth HW, Lee SWH, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002; 17: 332\u2013336.","journal-title":"Hum Reprod"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0010-7824(00)00187-6","article-title":"Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost","volume":"62","author":"Bartley, J.; Tong, S.; Everington, D.; Baird, D.T.","year":"2000","unstructured":"Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000; 62: 297\u2013303.","journal-title":"Contraception"},{"key":"ref_55","article-title":"Obstetricians and Gynaecologists (RCOG) Clinical Effectiveness Support Unit. The Care of Women Requesting Induced Abortion","author":"of, Royal College","year":"2000","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG) Clinical Effectiveness Support Unit. The Care of Women Requesting Induced Abortion. London, UK: RCOG Press, 2000."},{"issue":"3","key":"ref_56","first-page":"133","article-title":"Research on regimens for early medical abortion","volume":"55","author":"von Hertzen H","year":"2000","unstructured":"von Hertzen H. Research on regimens for early medical abortion. J Am Med Womens Assoc 2000; 55(3 Suppl.): 133\u2013136.","journal-title":"J Am Med Womens Assoc"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00006254-199909000-00024","article-title":"Use of misoprostol in first and second trimester abortion: a review","volume":"54","author":"Scheepers, H.C.J.; Van Erp, E.J.M.; Van den Bergh, A.S.","year":"1999","unstructured":"Scheepers HCJ, Van Erp EJM, Van den Bergh AS. Use of misoprostol in first and second trimester abortion: a review. Obstet Gynecol Surv 1999; 54: 592\u2013600.","journal-title":"Obstet Gynecol Surv"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1471-0528.2000.tb13272.x","article-title":"Epidemiological assessment of misoprostol teratogenicity","volume":"107","author":"Orioli, I.M.; Castilla, E.E.","year":"2000","unstructured":"Orioli IM, Castilla EE. Epidemiological assessment of misoprostol teratogenicity. Br J Obstet Gynaecol 2000; 107: 519\u2013523.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00006254-200301000-00023","article-title":"Long-term physical and psychological health consequences of induced abortion: review of the evidence","volume":"58","author":"JM, Jr, Thorp; KE, Hartmann; E, Shadigian","year":"2003","unstructured":"Thorp JM Jr, Hartmann KE, Shadigian E. Long-term physical and psychological health consequences of induced abortion: review of the evidence. Obstet Gynecol Surv 2003; 58: 67\u201379.","journal-title":"Obstet Gynecol Surv"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.324.7330.151","article-title":"Depression and unintended pregnancy in the National Longitudinal Survey of Youth: a cohort study","volume":"324","author":"Reardon, D.C.; Cougle, JR","year":"2002","unstructured":"Reardon DC, Cougle JR. Depression and unintended pregnancy in the National Longitudinal Survey of Youth: a cohort study. BMJ 2002; 324: 151\u2013152.","journal-title":"BMJ"},{"key":"ref_61","first-page":"1253","article-title":"Psychiatric admissions of low-income women following abortion and childbirth (see Comment)","volume":"168","author":"Reardon, D.C.; Cougle, JR, Rue; VM, Shuping; MW, Coleman; PK, Ney; P.G.","year":"2003","unstructured":"Reardon DC, Cougle JR, Rue VM, Shuping MW, Coleman PK, Ney PG. Psychiatric admissions of low-income women following abortion and childbirth (see Comment). CMAJ 2003; 168: 1253\u20131256.","journal-title":"CMAJ"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00007611-200295080-00011","article-title":"Deaths associated with pregnancy outcome: a record linkage study of low-income women","volume":"95","author":"Reardon, D.C.; Ney, P.G.; Scheuren, F.; Cougle, J.; Coleman, P.K.; Strahan, T.W.","year":"2002","unstructured":"Reardon DC, Ney PG, Scheuren F, Cougle J, Coleman PK, Strahan TW. Deaths associated with pregnancy outcome: a record linkage study of low-income women. South Med J 2002; 95: 834\u2013841.","journal-title":"South Med J"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/bmj.313.7070.1431","article-title":"Suicides after pregnancy in Finland, 1987\u201394: register linkage study","volume":"313","author":"Gissler, M.; Hemminki, E.; Lonnqvist, J.","year":"1996","unstructured":"Gissler M, Hemminki E, Lonnqvist J. Suicides after pregnancy in Finland, 1987\u201394: register linkage study. BMJ 1996; 313: 1431\u20131434.","journal-title":"BMJ"},{"key":"ref_64","article-title":"Suicides after pregnancy. Mental health may deteriorate as a direct effect of induced abortion","author":"Morgan, C.L.; Evans, M.; Peters, JR","year":"1997","unstructured":"Morgan CL, Evans M, Peters JR. Suicides after pregnancy. Mental health may deteriorate as a direct effect of induced abortion. BMJ 1997; 314: 902; author reply 902\u2013903.","journal-title":"BMJ; 314: 902; author reply 902\u2013903"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2307\/2136257","article-title":"Acceptability of medical abortion in early pregnancy","volume":"27","author":"Winikoff, B.","year":"1995","unstructured":"Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect 1995; 27: 142\u2013148, 185.","journal-title":"Fam Plann Perspect"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/3097714","article-title":"Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden (Special Report)","volume":"34","author":"Jones, R.K.; Henshaw, S.K.","year":"2002","unstructured":"Jones RK, Henshaw SK. Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden (Special Report). Perspect Sex Reprod Health 2002; 34: 154\u2013161. See also http:\/\/www.agi-usa.org\/pubs\/journals\/3415402.html#16a [Accessed 20 August 2004].","journal-title":"Perspect Sex Reprod Health"},{"key":"ref_67","author":"Abortion Statistics for England and Wales","year":"2002","unstructured":"Abortion Statistics for England and Wales 2002. Department of Health Bulletin 2003\/23. London, UK: Department of Health, 2003.","journal-title":"Department of Health Bulletin"},{"key":"ref_68","article-title":"Abortion Statistics in Scotland 2002 \u2013 ISD Scotland Health Briefing","author":"Information and Statistics Division (ISD","year":"2003","unstructured":"Information and Statistics Division (ISD). Abortion Statistics in Scotland 2002 \u2013 ISD Scotland Health Briefing. Edinburgh, UK: ISD, 2003."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mob.2000.107950","article-title":"Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions","volume":"183","author":"Newhall, E.P.; Winikoff, B.","year":"2000","unstructured":"Newhall EP, Winikoff B. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions. Am J Obstet Gynecol 2000; 183(Suppl.): S44\u2013S53.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0010-7824(97)00184-4","article-title":"Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. UK Multicentre Study Group","volume":"56","year":"1997","unstructured":"Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. UK Multicentre Study Group. Contraception 1997; 56: 361\u2013366.","journal-title":"Contraception"},{"key":"ref_71","first-page":"225","article-title":"Predictors of analgesia use during supervised medical abortion","volume":"61","author":"Westhoff, C.; Dasmahapatra, R.; Winikoff, B.; Clarke, S.","year":"2000","unstructured":"Westhoff C, Dasmahapatra R, Winikoff B, Clarke S. Predictors of analgesia use during supervised medical abortion. The Mifepristone Clinical Trials Group. Contraception 2000; 61: 225\u2013229.","journal-title":"The Mifepristone Clinical Trials Group. Contraception"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0010-7824(00)00186-4","article-title":"Analgesia during at-home use of misoprostol as part of a medical abortion regimen","volume":"62","author":"Westhoff, C.; Dasmahapatra, R.; Schaff, E.","year":"2000","unstructured":"Westhoff C, Dasmahapatra R, Schaff E. Analgesia during at-home use of misoprostol as part of a medical abortion regimen. Contraception 2000; 62: 311\u2013314.","journal-title":"Contraception"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1471-0528.2004.00235.x","article-title":"Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation","volume":"111","author":"Hamoda, H.; Ashok, P.W.; Flett, G.M.; Templeton, A.","year":"2004","unstructured":"Hamoda H, Ashok PW, Flett GM, Templeton A. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. Br J Obstet Gynaecol 2004; 111: 996\u20131000.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_74","first-page":"353","article-title":"Vaginal misoprostol administered at home after mifepristone (RU486) for abortion","volume":"44","author":"Schaff, E.A.; Stadalius, L.S.; Eisinger, S.H.; Franks, P.","year":"1997","unstructured":"Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997; 44: 353\u2013360.","journal-title":"J Fam Pract"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial","volume":"284","author":"Schaff, E.A.; Fielding, S.L.; Westhoff, C.; Ellertson, C.; Eisinger, S.H.; Stadalius, L.S.","year":"2000","unstructured":"Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 2000; 284: 1948\u20131953.","journal-title":"JAMA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0010-7824(99)00119-5","article-title":"Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days","volume":"61","author":"Schaff, E.A.; Fielding, S.L.; Eisinger, S.H.; Stadalius, L.S.; Fuller, L.","year":"2000","unstructured":"Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000; 61: 41\u201346.","journal-title":"Contraception"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(98)00150-4","article-title":"and vaginal misoprostol for abortion","volume":"59","author":"Schaff, E.A.; Eisinger, S.H.; Stadalius, L.S.; Franks, P.; Gore, B.Z.; Poppema, S.","year":"1999","unstructured":"Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999; 59: 1\u20136.","journal-title":"Contraception"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0010-7824(01)00228-1","article-title":"Mifepristone followed on the same day by vaginal misoprostol for early abortion","volume":"64","author":"Pymar, H.C.; Creinin, M.D.; Schwartz, J.L.","year":"2001","unstructured":"Pymar HC, Creinin MD, Schwartz JL. Mifepristone followed on the same day by vaginal misoprostol for early abortion. Contraception 2001; 64: 87\u201392.","journal-title":"Contraception"},{"key":"ref_79","article-title":"The acceptability of home medical abortion to women in UK settings","author":"Hamoda, H.; Critchley, H.O.D.; Paterson, K.; Guthrie, K.; Rodger, M.; Penney, G.C.","unstructured":"Hamoda H, Critchley HOD, Paterson K, Guthrie K, Rodger M, Penney GC. The acceptability of home medical abortion to women in UK settings. Br J Obstet Gynaecol (in press).","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_80","article-title":"World Health Organization (WHO). Safe abortion: technical and policy guidance for health systems","author":"[20 August 2004].","year":"2003","unstructured":"World Health Organization (WHO). Safe abortion: technical and policy guidance for health systems. Geneva, Switzerland: WHO, 2003. http:\/\/www.who.int\/reproductive-health [Accessed 20 August 2004]."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/01.AOG.0000115511.14004.19","article-title":"Routine follow-up visits after first-trimester induced abortion","volume":"103","author":"Grossman, D.; Ellertson, C.; Grimes, D.A.; Walker, D.","year":"2004","unstructured":"Grossman D, Ellertson C, Grimes DA, Walker D. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol 2004; 103: 738\u2013745.","journal-title":"Obstet Gynecol"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0029-7844(97)81439-1","article-title":"Medical abortion in early pregnancy: a review of the evidence","volume":"1","author":"Grimes, D.A.","year":"1997","unstructured":"Grimes DA. Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol 1997; 89(5 Pt 1): 790\u2013796.","journal-title":"Obstet Gynecol"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/oxfordjournals.humrep.a138412","article-title":"A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae","volume":"9","author":"Henshaw, R.C.; Naji, S.A.; Russell, I.T.; Templeton, A.A.","year":"1994","unstructured":"Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod 1994; 9: 2167\u20132172.","journal-title":"Hum Reprod"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bmj.307.6906.714","article-title":"Comparison of medical abortion with surgical vacuum aspiration: women\u2019s preferences and acceptability of treatment","volume":"307","author":"Henshaw, R.C.; Naji, S.A.; Russell, I.T.; Templeton, A.A.","year":"1993","unstructured":"Henshaw RC, Naji SA, Russell IT, Templeton AA. Comparison of medical abortion with surgical vacuum aspiration: women\u2019s preferences and acceptability of treatment. BMJ 1993; 307: 714\u2013717.","journal-title":"BMJ"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3109\/00016349409072511","article-title":"Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study","volume":"73","author":"Henshaw, R.; Naji, S.; Russell, I.; Templeton, A.","year":"1994","unstructured":"Henshaw R, Naji S, Russell I, Templeton A. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study. Acta Obstet Gynecol Scand 1994; 73: 812\u2013818.","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/0000000052972906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:00:08Z","timestamp":1757095208000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/0000000052972906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,1,1]]},"published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1783\/0000000052972906"],"URL":"https:\/\/doi.org\/10.1783\/0000000052972906","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}